PRP vs Exosomes for Hair Loss: Which Treatment Is Right for You in 2026?

How PRP and Exosomes Actually Work: The Science Explained

Understanding the biological mechanisms behind each treatment is essential for making an informed decision.

PRP: Your Body's Own Growth Factors

PRP therapy uses a concentrated preparation of your own blood platelets to stimulate hair regrowth. The procedure involves drawing a small sample of blood, processing it in a medical centrifuge to isolate the platelet-rich plasma, and injecting this concentrated solution directly into the scalp at sites of thinning.

The platelets contain a potent cocktail of growth factors — including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-β), epidermal growth factor (EGF), and insulin-like growth factor (IGF) — that collectively activate dormant hair follicles, extend the anagen (growth) phase of the hair cycle, and improve blood supply to the scalp.

PRP's mechanism of action is well-documented in peer-reviewed literature. A 2025 systematic review published in Dermatology and Therapy confirmed that PRP activates the Bcl-2 anti-apoptotic pathway and upregulates FGF-7/β-catenin signalling, which stimulates hair follicle stem cell differentiation and prolongs active growth.

Exosomes: Lab-Derived Regenerative Messengers

Exosome therapy uses extracellular vesicles — tiny membrane-bound particles typically 50–150 nanometres in size — that are derived from mesenchymal stem cells cultured in a laboratory. These nano-scale messengers carry proteins, growth factors, cytokines, microRNAs, and other bioactive molecules that facilitate cell-to-cell communication and promote tissue regeneration.

Unlike PRP, exosomes are not autologous (they don't come from your own body). They are applied to the scalp via injection or microneedling and work by delivering regenerative signals directly to hair follicles, potentially reactivating dormant follicles and reducing the inflammatory microenvironment that contributes to hair loss.

At The London PRP Clinic, we offer ExoRevive exosome therapy as a standalone treatment or in combination with PRP for patients who may benefit from this dual approach.

PRP vs Exosomes: Head-to-Head Comparison

Clinical Evidence

This is where the two treatments diverge most significantly.

PRP: Backed by robust clinical evidence. A landmark 2025 meta-analysis analysed 43 randomised controlled trials involving 1,877 participants and concluded that activated PRP significantly increases hair density, reduces hair loss, and improves clinical outcomes and patient satisfaction compared to placebo. An additional 2025 systematic review published in Skin Health and Disease found PRP's efficacy to be comparable to topical minoxidil — the FDA-approved gold standard — with minimal adverse effects on long-term follow-up. The evidence base is categorised as "moderate" quality, which is strong for a regenerative therapy.

Exosomes: Promising but early-stage. Most published evidence comes from smaller case series, observational studies, and preclinical research. A 2025 systematic review in PMC comparing exosomes, PRP, and minoxidil concluded that exosomes show "the most promising results" in early data but noted the critical need for larger, standardised trials. As of March 2026, no large-scale randomised controlled trial exclusively evaluating exosome therapy for androgenetic alopecia has been published.

Verdict: PRP wins on evidence strength. Exosomes are promising but unproven at scale.

Results Timeline

PRP: Gradual improvement. Most patients notice reduced shedding within 2–3 weeks, with visible improvements in hair density and thickness emerging at 3–6 months. A 2025 meta-analysis found an average 31% increase in hair density after 6 months of treatment.

Exosomes: Potentially faster initial response. Clinical observations suggest some patients notice changes in hair texture and reduced shedding within 4 weeks, with density improvements visible at 2–3 months. However, these findings are based on smaller datasets.

Verdict: Exosomes may offer slightly faster initial results, but PRP's 6-month outcomes are backed by far more robust data.

How Long Results Last

PRP: Results typically persist for 12–18 months before maintenance treatment is needed. Most protocols recommend follow-up sessions every 6–12 months based on individual response.

Exosomes: Early clinical data suggests results may last slightly longer due to the concentrated regenerative cargo, but long-term follow-up data beyond 12 months remains limited.

Verdict: Both require ongoing maintenance. PRP has better-documented long-term outcomes.

Treatment Protocol

PRP: An initial course of 3–4 sessions spaced 4–6 weeks apart, followed by maintenance sessions every 6–12 months. Each session takes approximately 45–60 minutes.

Exosomes: Typically 2–3 sessions spaced 4–8 weeks apart, with maintenance every 6–12 months. Sessions may be shorter as there is no blood draw required.

Verdict: Exosomes may require fewer initial sessions.

Safety Profile

PRP: Excellent safety record. Because PRP is autologous (made from your own blood), there is virtually no risk of allergic reaction, rejection, or disease transmission. The 2025 meta-analysis reported only mild, transient side effects: temporary scalp sensitivity (15% of cases), mild swelling (resolves within 24–48 hours), and minor headache (less than 10%).

Exosomes: Generally well-tolerated, but because exosomes are derived from lab-cultured stem cells (not your own biology), there is a theoretical — though very low — risk of adverse reaction. Regulatory frameworks for exosome products are still evolving in the UK, and product quality can vary significantly between clinics.

Verdict: PRP has the superior safety profile due to its autologous nature.

Cost Comparison (London, 2026)

PRP: £175–£850 per session across London. At The London PRP Clinic, PRP costs £545 per session or £1,455 for a recommended course of three sessions.

Exosomes: £320–£500 per session at The London PRP Clinic (ExoRevive). Combined PRP + ExoRevive sessions cost £500.

PRP + Exosome Combination: £500 per session at The London PRP Clinic, offering both biological pathways in a single appointment.

Verdict: PRP is generally more cost-effective per session. Exosomes may offer value through fewer required sessions.

Which Treatment Is Right for Your Stage of Hair Loss?

Early-Stage Hair Loss (Norwood I–III / Ludwig I)

Recommended: PRP

If you're in the early stages of thinning — a slightly receding hairline, minor crown thinning, or diffuse thinning at the parting — PRP is the strongest evidence-based option. Clinical trials consistently show the best results in patients with early-stage hair loss where follicles are miniaturised but still active. Starting PRP early can serve as a powerful preventive measure, preserving existing follicles before significant density is lost.

Moderate Hair Loss (Norwood III–IV / Ludwig II)

Recommended: PRP or PRP + Exosome Combination

For moderate thinning with noticeable density loss, PRP remains the primary recommendation. However, this is the stage where combining PRP with exosome therapy may offer additional benefit. The complementary biological mechanisms — PRP's autologous growth factors plus exosomes' regenerative signalling molecules — may create a more potent stimulus for follicular regeneration. Our doctors assess each patient individually to determine whether combination therapy is appropriate.

Advanced Hair Loss (Norwood V+ / Ludwig III)

Recommended: Combination Therapy + Hair Transplant Consultation

For advanced hair loss where significant follicular miniaturisation has occurred, neither PRP nor exosomes alone is likely to produce dramatic regrowth. At this stage, our doctors may recommend PRP or combination therapy as a supportive treatment alongside hair transplant surgery. PRP has been shown to enhance graft survival, reduce post-transplant shedding, and accelerate recovery when used as a pre-conditioning and post-transplant therapy. The London PRP Clinic works with partner transplant surgeons to create comprehensive restoration plans.

Not sure which stage you're at? Send us a photo on WhatsApp for a free assessment →

Why Combination Therapy Is Gaining Momentum in 2026

The most significant shift in hair restoration in 2026 is the move toward multi-modal combination protocols. Leading dermatologists no longer prescribe single-agent treatments as the default.

A landmark clinical study published in Dermatologic Therapy demonstrated a 94.1% improvement rate with combination therapy (finasteride + minoxidil), compared to 80.5% with finasteride alone and 59% with minoxidil alone. When PRP is added to pharmaceutical combinations, outcomes improve further.

At The London PRP Clinic, our doctors design personalised multi-layered treatment plans that may include PRP therapy as the regenerative foundation, ExoRevive exosome therapy for enhanced cellular signalling, medical-grade supplements (Viviscal Professional) for nutritional support, and referral for pharmaceutical therapy (minoxidil, finasteride, spironolactone) where clinically appropriate.

This comprehensive approach — addressing hair loss from biological, nutritional, and pharmaceutical angles simultaneously — consistently produces superior outcomes compared to any single treatment in isolation.

The PRP Market in 2026: What the Data Shows

The regenerative hair restoration market is growing rapidly. The U.S. PRP and stem cell alopecia treatment market was valued at $279.88 million in 2025 and is projected to reach $692.97 million by 2035, growing at 9.49% annually. PRP therapy dominated market share in 2025 due to its affordability, accessibility, and strong clinical outcomes.

This growth reflects increasing patient confidence in regenerative approaches as clinical evidence strengthens. For patients in London, this means more treatment options, better-trained practitioners, and more competitive pricing than ever before.

Why Patients Choose The London PRP Clinic

87% documented success rate across all PRP hair restoration patients — significantly above the industry average of 70–80%.

GMC-registered doctors only. Every treatment is performed by a qualified medical doctor, not a beautician or aesthetician. This is critical for both safety and efficacy.

Both PRP and ExoRevive exosome therapy available under one roof, allowing our doctors to recommend the genuinely best option for your specific case — without being limited to a single treatment modality.

187+ five-star reviews from verified patients who have experienced measurable results.

Transparent pricing with no hidden costs: PRP at £545/session, ExoRevive at £445/session, or combined PRP + ExoRevive at £500/session.

Central London location in Marylebone, near Baker Street station, with same-week appointments available.

Book your free consultation on WhatsApp → or email team@thewellnesslondon.com

Frequently Asked Questions

Is PRP or exosome therapy better for hair loss?

PRP is better supported by clinical evidence, with 43 randomised controlled trials confirming significant improvements in hair density. Exosome therapy shows promise in early studies but lacks large-scale clinical validation. For most patients with early-to-moderate hair loss, PRP is the recommended first-line regenerative treatment. Exosomes may be considered as an adjunct or alternative for patients who have not responded optimally to PRP alone.

How much does PRP vs exosome treatment cost in London?

PRP ranges from £175 to £850 per session across London clinics. Exosome therapy typically costs £320–£500 per session. At The London PRP Clinic, PRP costs £545/session (or £1,455 for three), ExoRevive costs £445/session, and combined PRP + ExoRevive costs £500/session.

Can PRP and exosomes be combined for hair loss?

Yes. Combining PRP and exosome therapy targets hair loss through complementary biological pathways and may produce superior results compared to either treatment alone. The London PRP Clinic offers combined sessions for patients who may benefit from this approach.

How long do PRP and exosome results last?

PRP results typically persist 12–18 months before maintenance is needed. Exosome results may last slightly longer but long-term data is limited. Both treatments require ongoing maintenance sessions for sustained results.

What does the clinical evidence say about PRP vs exosomes in 2026?

PRP is supported by a 2025 meta-analysis of 43 RCTs (1,877 participants) confirming it significantly increases hair density and reduces hair loss. Exosome evidence comes primarily from smaller studies and case series. PRP has substantially stronger evidence as of March 2026.

Who is the best candidate for PRP vs exosome therapy?

PRP is ideal for early-to-moderate thinning (Norwood I–IV, Ludwig I–II). Exosomes may suit patients with more advanced loss, those who have tried PRP without optimal results, or those who prefer fewer sessions. A consultation with a GMC-registered doctor is essential for personalised advice.

Take the Next Step

Hair loss is a medical condition, and the right treatment depends on your specific diagnosis, stage of loss, and overall health profile. At The London PRP Clinic, our GMC-registered doctors provide honest, evidence-based assessments — not sales pitches.

Whether PRP, exosome therapy, combination treatment, or a surgical referral is right for you, we will give you a clear, personalised recommendation based on clinical evidence and your individual circumstances.

Book your free consultation on WhatsApp →

Email: team@thewellnesslondon.com

Call/WhatsApp: 07961 280 835

Location: Marylebone, London (near Baker Street station)

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. PRP and exosome therapy results vary between individuals. All treatments at The London PRP Clinic are performed by GMC-registered doctors who will assess your suitability during a consultation. Last reviewed March 2026.

Previous
Previous

PRP Hair Treatment Cost in 2026: What You'll Actually Pay (Complete UK Price Guide)

Next
Next

Peptide Therapy for Healing in 2026: What You Need to Know About BPC-157, TB-500, and the Evidence-Based Alternatives Available in London